Overview
Joo-won Jeong practices practicing medicine in Seoul, Republic of Korea.
Their clinical expertise encompasses Secondary Parkinsonism, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 35 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Joo-won Jeong
Is Joo-won Jeong a top-rated expert for Secondary Parkinsonism?
MediFind is an objective health platform that identifies experts based on real-world data. Joo-won Jeong is classified as an Experienced expert for Secondary Parkinsonism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Joo-won Jeong participate in research or clinical trials?
Yes. Joo-won Jeong has published 35 articles and abstracts on conditions like Secondary Parkinsonism. You can view a list of Joo-won Jeong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerJeong isExperienced. Learn about Lung Cancer.
- Neurotoxicity SyndromesJeong isExperienced. Learn about Neurotoxicity Syndromes.
- Non-Small Cell Lung Cancer (NSCLC)
- Secondary ParkinsonismJeong isExperienced. Learn about Secondary Parkinsonism.